Immediate test results and patient treatment reduces the likelihood of a readmission “within 30 days of discharge” that could result in hospital penalties under Accountable Care.
“Consolidates and replaces a suitcase full of readers with a single device, that adapts to existing and FDA Cleared Point of Care tests, eliminates transportation of patient samples to central labs by testing the patient wherever they are, and transmits test results directly to The Cloud. The device that finally makes Point of Care diagnostics practical for healthcare providers."
As you know iAssay’s CyberReader™ and SimpleTest 2™ Point of Care Diagnostics instruments are connected to the company’s SimpleCloud™ data management Cloud. The instruments are assay format and technology agnostic and are fully capable of reading lateral flow-type Rapid Diagnostics Tests. Recently, FIND, the global alliance for diagnostics, and the World Health Organization released a […]
Founded in 2014 by CEO, Lonnie Adelman, and located in San Diego CA, iAssay provides a cutting edge interoperable system composed of a universal point of care diagnostics device (SimpleTest 2(TM) and CyberReader(TM) ) and an iAssay developed HIPAA compliant AWS Cloud, SimpleCloud(TM). iAssay has continually innovated and provided reliable solutions and products around these […]
iAssay is proud to have been a Corporate Sponsor for the UCSD MAE 156 program. iAssay sponsored 4 UCSD Mechanical and Aerospace Engineering Seniors’ capstone project. In addition to representing the Sponsor, it was my privilege to advise on the electrical and thermal engineering side of the project. Our UCSD engineering team produced a functioning […]
SAN DIEGO, CA – May 3, 2022 – iAssay® Inc., a privately held developer of the world’s first open platform, point of care (POC) reader and data management system for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has granted patent number 11,320,418. The patent includes nineteen claims, key […]
San Diego – April 10, 2022 – The recent HIMSS22 exhibition in Orlando, Florida was a resounding success for iAssay. Over the course of the event: • iAssay performed more than 25 perfect demos for booth visitors. • Numerous potential partners in the Health IT, pharmaceutical, and financial sectors were identified. • Multiple media editors […]
iAssay is thrilled to be included in Medical Product Outsourcing Magazine’s “Point-of-Care Diagnostics on Display at HIMSS 2022” article. Learn more about iAssay’s unique patent protected approach to the Cloud-connected interoperable point of care diagnostics that makes us stand out. Please reach out to info@iAssay.net to setup a call and learn more. #HIMSS22 #reimaginehealth #pointofcare
We are excited to have been noticed by a very respected publisher on life science topics: 360Dx! We were interviewed at our booth at HIMSS22, and were surprised to see this great article about iAssay appear Thursday night. See the full article here For more information, and to inquire about investments in iAssay, contact Lonnie […]
For Release March 23, 2022 FIND, the Global Alliance for Diagnostics and the iAssay Team Up to Develop Diagnostics San Diego — March 23, 2022 — Buruli ulcer is a severely debilitating disease, which starts as an inconspicuous papule and degenerates in large open wounds if left untreated. The causative pathogen is Mycobacterium ulcerans. Treatments […]